Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-020276

Director sold 20,000 shares at $38.25 ($765,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
MARCUS JOEL S Director 2019-03-15 Sale −20,000 $38.25 $765,000 888,355 I
Open-market sales · 20,000 sh · avg $38.25 · $765,000
Loading xslF345X03/doc4.xml…